September 2013 FDA Recall Drug by Watson Laboratories Inc
D-66251-001 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Watson Laboratories Inc on September 13, 2013 for the product Drug. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-66251-001

Reason for Recall
Presence of Foreign Tablets/Capsules: 20 tablets of Oxycodone/APAP 7.5/500 mg were found in a sealed 100 count bottle of Oxycodone and Acetaminophen Tablets, USP 10/650 mg lot# 705791A.
Initiated
09-13-2013
Reported
10-09-2013
Quantity
10,615 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Watson Laboratories Inc
Oxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII, 100 Count Bottles, Rx Only, Manufactured by: Watson Laboratories, Inc. Corona, CA 92880 USA, NDC 0591-0825-01

Batch or Lot Expiration Information

Lot# : 705791A, Exp 04/2015